1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
2
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hoshida Y, Villanueva A and Llovet JM:
Molecular profiling to predict hepatocellular carcinoma outcome.
Expert Rev Gastroenterol Hepatol. 3:101–103. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Okada S, Shimada K, Yamamoto J, Takayama
T, Kosuge T, Yamasaki S, Sakamoto M and Hirohashi S: Predictive
factors for postoperative recurrence of hepatocellular carcinoma.
Gastroenterology. 106:1618–1624. 1994.PubMed/NCBI
|
6
|
Csiszar A, Podlutsky A, Podlutskaya N,
Sonntag WE, Merlin SZ, Philipp EE, Doyle K, Davila A, Recchia FA,
Ballabh P, et al: Testing the oxidative stress hypothesis of aging
in primate fibroblasts: Is there a correlation between species
longevity and cellular ROS production? J Gerontol A Biol Sci Med
Sci. 67:841–852. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Park J, Lee J and Choi C: Mitochondrial
network determines intracellular ROS dynamics and sensitivity to
oxidative stress through switching inter-mitochondrial messengers.
PLoS One. 6:e232112011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kawanishi S, Hiraku Y and Oikawa S:
Mechanism of guanine-specific DNA damage by oxidative stress and
its role in carcinogenesis and aging. Mutat Res. 488:65–76. 2001.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Valko M, Leibfritz D, Moncol J, Cronin MT,
Mazur M and Telser J: Free radicals and antioxidants in normal
physiological functions and human disease. Int J Biochem Cell Biol.
39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
DeNicola GM, Karreth FA, Humpton TJ,
Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES,
et al: Oncogene-induced Nrf2 transcription promotes ROS
detoxification and tumorigenesis. Nature. 475:106–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
11
|
DiMauro S and Schon EA: Mitochondrial DNA
mutations in human disease. Am J Med Genet. 106:18–26. 2001.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Lightowlers RN, Chinnery PF, Turnbull DM
and Howell N: Mammalian mitochondrial genetics: Heredity,
heteroplasmy and disease. Trends Genet. 13:450–455. 1997.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Yang L, Wang P, Wang H, Li Q, Teng H, Liu
Z, Yang W, Hou L and Zou X: Fucoidan derived from Undaria
pinnatifida induces apoptosis in human hepatocellular carcinoma
SMMC-7721 cells via the ROS-mediated mitochondrial pathway. Mar
Drugs. 11:1961–1976. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Quinlan CL, Orr AL, Perevoshchikova IV,
Treberg JR, Ackrell BA and Brand MD: Mitochondrial complex II can
generate reactive oxygen species at high rates in both the forward
and reverse reactions. J Biol Chem. 287:27255–27264. 2012.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Moreno-Sánchez R, Hernández-Esquivel L,
Rivero-Segura NA, Marín-Hernández A, Neuzil J, Ralph SJ and
Rodríguez Enríquez S: Reactive oxygen species are generated by the
respiratory complex II - evidence for lack of contribution of the
reverse electron flow in complex I. FEBS J. 280:927–938.
2013.PubMed/NCBI
|
16
|
Hoekstra AS and Bayley JP: The role of
complex II in disease. Biochim Biophys Acta. 1827:543–551. 2013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Halliwell B: Can oxidative DNA damage be
used as a biomarker of cancer risk in humans? Problems, resolutions
and preliminary results from nutritional supplementation studies.
Free Radic Res. 29:469–486. 1998. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li S, Wang X, Wu Y, Zhang H, Zhang L, Wang
C, Zhang R and Guo Z: 8-Hydroxy-2′-deoxyguanosine expression
predicts hepatocellular carcinoma outcome. Oncol Lett. 3:338–342.
2012.PubMed/NCBI
|
19
|
Cheng CW, Kuo CY, Fan CC, Fang WC, Jiang
SS, Lo YK, Wang TY, Kao MC and Lee AY: Overexpression of Lon
contributes to survival and aggressive phenotype of cancer cells
through mitochondrial complex I-mediated generation of reactive
oxygen species. Cell Death Dis. 4:e6812013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Inoue S and Kawanishi S: Oxidative DNA
damage induced by simultaneous generation of nitric oxide and
superoxide. FEBS Lett. 371:86–88. 1995. View Article : Google Scholar : PubMed/NCBI
|
21
|
Erhola M, Toyokuni S, Okada K, Tanaka T,
Hiai H, Ochi H, Uchida K, Osawa T, Nieminen MM, Alho H, et al:
Biomarker evidence of DNA oxidation in lung cancer patients:
Association of urinary 8-hydroxy-2′-deoxyguanosine excretion with
radiotherapy, chemotherapy, and response to treatment. FEBS Lett.
409:287–291. 1997. View Article : Google Scholar : PubMed/NCBI
|
22
|
Miyake H, Hara I, Gleave ME and Eto H:
Protection of androgen-dependent human prostate cancer cells from
oxidative stress-induced DNA damage by overexpression of clusterin
and its modulation by androgen. Prostate. 61:318–323. 2004.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Kluckova K, Bezawork-Geleta A, Rohlena J,
Dong L and Neuzil J: Mitochondrial complex II, a novel target for
anti-cancer agents. Biochim Biophys Acta. 1827:552–564. 2013.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Albayrak T, Scherhammer V, Schoenfeld N,
Braziulis E, Mund T, Bauer MK, Scheffler IE and Grimm S: The tumor
suppressor cybL, a component of the respiratory chain, mediates
apoptosis induction. Mol Biol Cell. 14:3082–3096. 2003. View Article : Google Scholar : PubMed/NCBI
|